WallStreetZenWallStreetZen

NASDAQ: RVMD
Revolution Medicines Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RVMD past revenue growth

How has RVMD's revenue growth performed historically?
Company
-67.27%
Industry
144.63%
Market
17.55%
RVMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RVMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RVMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RVMD earnings and revenue history

Current Revenue
$11.6M
Current Earnings
-$436.4M
Current Profit Margin
-3,768.3%

RVMD Return on Equity

Current Company
-38.4%
Current Industry
-63.5%
Current Market
188%
RVMD's Return on Equity (-38.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RVMD announces earnings.

RVMD Return on Assets

Current Company
-33.6%
Current Industry
2.9%
RVMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RVMD Return on Capital Employed

Current Company
-22.92%
Current Industry
19.5%
RVMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RVMD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RVMD$11.58M-$430.28M-$436.37M-10.50%N/A
APLS$396.59M-$495.21M-$528.63M+83.50%N/A
IONS$787.65M-$230.01M-$366.29M+5.60%N/A
BPMC$249.38M-$466.45M-$506.98M+41.14%N/A
PCVX$0.00-$392.10M-$402.27MN/AN/A
View Top Biotech Stocks

RVMD earnings dates

Next earnings date
Jun 7, 2024

Revolution Medicines Earnings & Revenue FAQ

What were RVMD's earnings last quarter?

On Invalid Date, Revolution Medicines (NASDAQ: RVMD) reported Q4 2023 earnings per share (EPS) of -$1.21, up 98.36% year over year. Total Revolution Medicines earnings for the quarter were -$161.54 million. In the same quarter last year, Revolution Medicines's earnings per share (EPS) was -$0.61.

If you're new to stock investing, here's how to buy Revolution Medicines stock.

What was RVMD's earnings growth in the past year?

As of Q2 2024, Revolution Medicines's earnings has grown year over year. Revolution Medicines's earnings in the past year totalled -$436.37 million.

What is RVMD's earnings date?

Revolution Medicines's earnings date is Invalid Date. Add RVMD to your watchlist to be reminded of RVMD's next earnings announcement.

What was RVMD's revenue last quarter?

On Invalid Date, Revolution Medicines (NASDAQ: RVMD) reported Q4 2023 revenue of $742.00 thousand up 95.16% year over year. In the same quarter last year, Revolution Medicines's revenue was $15.33 million.

What was RVMD's revenue growth in the past year?

As of Q2 2024, Revolution Medicines's revenue has grown -67.27% year over year. This is 211.9 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Revolution Medicines's revenue in the past year totalled $11.58 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.